Abstract
Early diagnosis of gastric cancer and its differential diagnosis from other non-malignant gastric diseases like gastritis is still a major clinical problem. Most patients are asymptomatic in the early stages of gastric cancer, and there is no reliable marker available for the early and specific diagnosis of gastric cancer. Many attempts have been made to define the biological profile of gastric cancer to improve the chances of its early diagnosis, prognosis and treatment. Several studies have shown the aberrant expression profile of mucins in different malignancies, suggesting that mucins have a great potential to be used as a diagnostic and prognostic marker in gastric cancer. In this review, we have briefly described the different types of gastric adenocarcinomas and the progression of gastric cancer. Furthermore, the role of mucins and their related carbohydrate epitope is discussed in the normal stomach and in the diagnosis and prognosis of gastric adenocarcinomas.
| Original language | English |
|---|---|
| Pages (from-to) | 1541-1552 |
| Number of pages | 12 |
| Journal | Histology and Histopathology |
| Volume | 23 |
| Issue number | 12 |
| State | Published - 2008 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Histology
- Pathology and Forensic Medicine
Cite this
The MUC gene family : Their role in the diagnosis and prognosis of gastric cancer. / Senapati, Shantibhusan; Sharma, Poonam K; Bafna, Sangeeta; Roy, Hemant K.; Batra, Surinder K.
In: Histology and Histopathology, Vol. 23, No. 12, 2008, p. 1541-1552.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - The MUC gene family
T2 - Their role in the diagnosis and prognosis of gastric cancer
AU - Senapati, Shantibhusan
AU - Sharma, Poonam K
AU - Bafna, Sangeeta
AU - Roy, Hemant K.
AU - Batra, Surinder K.
PY - 2008
Y1 - 2008
N2 - Early diagnosis of gastric cancer and its differential diagnosis from other non-malignant gastric diseases like gastritis is still a major clinical problem. Most patients are asymptomatic in the early stages of gastric cancer, and there is no reliable marker available for the early and specific diagnosis of gastric cancer. Many attempts have been made to define the biological profile of gastric cancer to improve the chances of its early diagnosis, prognosis and treatment. Several studies have shown the aberrant expression profile of mucins in different malignancies, suggesting that mucins have a great potential to be used as a diagnostic and prognostic marker in gastric cancer. In this review, we have briefly described the different types of gastric adenocarcinomas and the progression of gastric cancer. Furthermore, the role of mucins and their related carbohydrate epitope is discussed in the normal stomach and in the diagnosis and prognosis of gastric adenocarcinomas.
AB - Early diagnosis of gastric cancer and its differential diagnosis from other non-malignant gastric diseases like gastritis is still a major clinical problem. Most patients are asymptomatic in the early stages of gastric cancer, and there is no reliable marker available for the early and specific diagnosis of gastric cancer. Many attempts have been made to define the biological profile of gastric cancer to improve the chances of its early diagnosis, prognosis and treatment. Several studies have shown the aberrant expression profile of mucins in different malignancies, suggesting that mucins have a great potential to be used as a diagnostic and prognostic marker in gastric cancer. In this review, we have briefly described the different types of gastric adenocarcinomas and the progression of gastric cancer. Furthermore, the role of mucins and their related carbohydrate epitope is discussed in the normal stomach and in the diagnosis and prognosis of gastric adenocarcinomas.
UR - http://www.scopus.com/inward/record.url?scp=58149291766&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58149291766&partnerID=8YFLogxK
M3 - Review article
VL - 23
SP - 1541
EP - 1552
JO - Histology and Histopathology
JF - Histology and Histopathology
SN - 0213-3911
IS - 12
ER -